News & Evens

2018 BiOptic Products

Product News


2018 - 01 - 01

BiOptic Inc. develops and commercializes innovative and revolutionary scientific products for the biotechnology industry.
The company was founded in 2004, with a vision of establishing a high-quality, value-added and customer-driven OEM/ODM solutions in developing and manufacturing CGE-based products for worldwide major biotechnology companies.
In the year 2009 BiOptic started the research and development of an innovative Capillary Gel Electrophoresis instrument utilizing disposable pen-shaped gel-cartridge. And launched the first patented CGE-based Fragment Analyzer Qsep100TM in the year 2011 at Lab Automation Conference in Palm Springs, CA.
For the past 7 years BiOptic has expanded its portfolio of products by developing and launching several CGE instruments of Qsep1TM, Gly-QTM, Qsep400TM and the mini-PCR machine, Qamp MiniTM, that incorporates newly launched innovative Direct-PCR reagent kits.
BiOptic strives to be the leader in biotechnology industry providing, easy-to-use and cost-effective CGE-based instruments. And provides innovative solutions for the world's top institutions and government laboratories.
Our team, having over 40 years of experience in the Capillary Electrophoresis has been recognized by our customers for its advanced instrumentation, superior customer service, scientific application support, and a very knowledgeable technical sales force.  With a company-wide commitment to quality and value, we serve professionals and laboratories for life science research, clinical diagnostics, pharmaceutical, food industry, animal husbandry and agriculture, performing diagnostic analysis in the molecular genetic analysis.


To Know more about BiOptic's Products